SMITH & NEPHEW PLC -SPON ADR (SNN) Stock Price, Forecast & Analysis
NYSE:SNN • US83175M2052
SNN Key Statistics, Chart & Performance
The current stock price of SNN is 36.18 USD. In the past month the price increased by 10%. In the past year, price increased by 40.78%.
SNN Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to SNN. When comparing the yearly performance of all stocks, SNN is one of the better performing stocks in the market, outperforming 83.96% of all stocks.
SNN Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to SNN. SNN has an excellent profitability rating, but there are some minor concerns on its financial health.
SNN Financial Highlights
Over the last trailing twelve months SNN reported a non-GAAP Earnings per Share(EPS) of 1.16. The EPS increased by 59.86% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 8.26% | ||
| ROA | 4.59% | ||
| ROE | 8.87% | ||
| Debt/Equity | 0.6 |
SNN Forecast & Estimates
24 analysts have analysed SNN and the average price target is 39.68 USD. This implies a price increase of 9.67% is expected in the next year compared to the current price of 36.18.
For the next year, analysts expect an EPS growth of 18.33% and a revenue growth 6.25% for SNN
SNN Ownership
SNN Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.62 | 195.936B | ||
| ISRG | INTUITIVE SURGICAL INC | 47.53 | 172.536B | ||
| SYK | STRYKER CORP | 24.21 | 139.985B | ||
| BSX | BOSTON SCIENTIFIC CORP | 21.34 | 110.826B | ||
| IDXX | IDEXX LABORATORIES INC | 42.48 | 50.254B | ||
| BDX | BECTON DICKINSON AND CO | 11.16 | 50.113B | ||
| EW | EDWARDS LIFESCIENCES CORP | 25.52 | 44.027B | ||
| RMD | RESMED INC | 20.57 | 36.792B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16 | 36.615B | ||
| DXCM | DEXCOM INC | 27.73 | 27.309B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About SNN
Company Profile
Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. The company is headquartered in Watford, Hertfordshire and currently employs 17,000 full-time employees. The firm is engaged in developing, manufacturing, marketing, and selling medical devices and services. The company is focused on the repair, regeneration, and replacement of soft and hard tissue. The firm's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
Company Info
SMITH & NEPHEW PLC -SPON ADR
Building 5, Croxley Park, Hatters Lane
Watford HERTFORDSHIRE WD18 8YE GB
CEO: Roland Diggelmann
Employees: 17349
Phone: 4401923477100
SMITH & NEPHEW PLC -SPON ADR / SNN FAQ
Can you describe the business of SMITH & NEPHEW PLC -SPON ADR?
Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. The company is headquartered in Watford, Hertfordshire and currently employs 17,000 full-time employees. The firm is engaged in developing, manufacturing, marketing, and selling medical devices and services. The company is focused on the repair, regeneration, and replacement of soft and hard tissue. The firm's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
What is the current price of SNN stock?
The current stock price of SNN is 36.18 USD. The price increased by 1.83% in the last trading session.
Does SNN stock pay dividends?
SMITH & NEPHEW PLC -SPON ADR (SNN) has a dividend yield of 2.2%. The yearly dividend amount is currently 0.37.
How is the ChartMill rating for SMITH & NEPHEW PLC -SPON ADR?
SNN has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Where is SMITH & NEPHEW PLC -SPON ADR (SNN) stock traded?
SNN stock is listed on the New York Stock Exchange exchange.
What sector and industry does SMITH & NEPHEW PLC -SPON ADR belong to?
SMITH & NEPHEW PLC -SPON ADR (SNN) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
When does SMITH & NEPHEW PLC -SPON ADR (SNN) report earnings?
SMITH & NEPHEW PLC -SPON ADR (SNN) will report earnings on 2026-03-02, after the market close.